Dirk G Engehausen
Overview
Explore the profile of Dirk G Engehausen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
89
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Latz S, Fisang C, Ebert W, Orth S, Engehausen D, Muller S, et al.
Case Rep Urol
. 2015 Apr;
2015:928787.
PMID: 25883827
Androgen deprivation is a common treatment option in patients with locally advanced or metastatic prostate cancer. No case of long term treatment with an intermittent approach with only low dose...
2.
Kunath F, Krause S, Wullich B, Goebell P, Engehausen D, Burger M, et al.
BMC Urol
. 2013 Oct;
13:56.
PMID: 24156254
Background: Uro-oncological neoplasms have both a high incidence and mortality rate and are therefore a major public health problem. The aim of this study was to evaluate research activity in...
3.
Apel H, Walschburger-Zorn K, Haberle L, Wach S, Engehausen D, Wullich B
Clin Transplant
. 2013 Jan;
27(1):E30-6.
PMID: 23278453
Purpose: Cancers complicating organ allografts are a major cause of morbidity and mortality after renal transplantation. Different registries have described an overall three to eightfold increase in cancer risk compared...
4.
Schwab S, Kuefner M, Adamietz B, Engelhard K, Keck B, Kunath F, et al.
Eur Radiol
. 2012 Nov;
23(5):1415-9.
PMID: 23179522
Objectives: To introduce a simplified technique for MRI-guided core biopsies (MRGB) of the prostate in the supine position using large-bore magnet systems. Methods: Fifty men with a history of negative...
5.
Rosenbaum C, Wach S, Kunath F, Wullich B, Scholbach T, Engehausen D
Urol Int
. 2012 Nov;
90(1):87-94.
PMID: 23154791
Introduction: Renal cell carcinoma (RCC) is characterized by intense angiogenesis with hyperexpression of proangiogenic factors. This study explored the potential of dynamic tissue perfusion measurement (DTPM) to detect differences in...
6.
Engehausen D, Engelhard K, Schwab S, Uder M, Wach S, Wullich B, et al.
ScientificWorldJournal
. 2012 Apr;
2012:975971.
PMID: 22489209
Aim: To explore the potential of transrectal magnetic resonance image- (MRI-) guided biopsies of the prostate in a patient cohort with prior negative ultrasound guided biopsies. Patients And Methods: Ninety-six...
7.
Weiss C, Wittlinger M, Engehausen D, Krause F, Ott O, Dunst J, et al.
Int J Radiat Oncol Biol Phys
. 2007 Oct;
70(5):1502-6.
PMID: 17935905
Purpose: Standard treatment for superficial bladder cancer is transurethral resection of the bladder tumor (TURBT) followed by intravesical therapy. Little is known about the biologic behavior and treatment response of...
8.
Weiss C, Engehausen D, Krause F, Papadopoulos T, Dunst J, Sauer R, et al.
Int J Radiat Oncol Biol Phys
. 2007 May;
68(4):1072-80.
PMID: 17467193
Purpose: To give an update on the long-term outcome of an intensified protocol of combined radiochemotherapy (RCT) with 5-fluorouracil (5-FU) and cisplatin after initial transurethral resection of bladder tumor (TURBT)...
9.
Goeb K, Engehausen D, Krause F, Hollenbach H, Niedobitek G, Buettner M, et al.
Anticancer Res
. 2007 Mar;
27(1B):687-93.
PMID: 17348461
Background: The purpose of this study was to evaluate the suitability of MR Spectroscopy in screening for prostate cancer in comparison to T2-weighted MR imaging. Materials And Methods: Forty-six patients...
10.
Krause F, Rauch A, Schrott K, Engehausen D
World J Urol
. 2006 May;
24(4):418-22.
PMID: 16688457
Non-invasive methods for detecting genetic alterations of bladder cancer are increasingly becoming the focus of attention as diagnostic tools. The fluorescence in situ hybridization we performed to detect genetic alterations...